Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
November 6, 2025
Cell and Gene Therapy Today—November 6, 2025
November 6, 2025
Rare Disease Video Recap—November 6, 2025
November 6, 2025
Rare Disease Today—November 6, 2025
November 6, 2025
Cardiovascular Video Recap—November, 6 2025
November 6, 2025
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A
November 6, 2025
Cardiovascular Today—November, 6 2025
November 5, 2025
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing
November 5, 2025
Neuroscience Today — November 5, 2025
November 5, 2025
Immunology Video Recap—November 5, 2025
November 5, 2025
Immunology Today—November 5, 2025
November 5, 2025
Lucid Diligence Brief: NEOK Bio $75M Series A
November 4, 2025